2016
The Establishment of Asia’s Largest Hematology Laboratory
The Establishment of the Telemedical Consultation Center
Successful Haplo-HSCT for a 69-year-old patient
In October 2016, transplantation specialists at our hospital performed a haploidentical hematopoietic stem cell transplant (Haplo-HSCT) for a 69-year-old patient with acute myeloid leukemia (AML), setting a new age record in Haplo-HSCT.
The 4th Lu Daopei Hematology Summit Forum
The fourth Lu Daopei Hematology Summit Forum was held at the Beijing International Convention Center in July 1, 2016.
The Lifetime Achievement Award to Professor Lu Daopei
In May 2016, at the 5th National Conference on Hematologic Oncology, Professor Lu received the Lifetime Achievement Award from the China Anti-Cancer Association.
The Distinguished Service Award to Professor Lu Daopei
In Feb. 2016, at the Tandem Meeting of Conference of American Society for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplantation Research (ASBMT-CIBMTR) held in Hawaii, Professor Lu Daopei received the Distinguished Service Award.
Took Leading Position in Transplantation for Aplastic Anemia
In January 2016, the outstanding clinical results achieved by Lu Daopei hospital in applying new conditioning program for Allo-HSCT to treat severe aplastic anemia (SAA) was published in China Hematology Journal. It was published under the title of Comparison of the Efficacy between Haplo-HSCT and Unrelated HSCT in SAA Treatment, marking our hospital’s leading position in transplantation for aplastic anemia.
Outstanding academic results were presented at the European Bone Marrow Transplant Annual Meeting (EBMT), the Asia-Pacific Bone Marrow Transplantation Annual Meeting (APBMT), the European hematology Association (EHA), and the American hematology academic year (ASH).
京公网安备13108202000843号